Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,165 JPY | +0.85% | +0.87% | +2.74% |
05-16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
05-15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.74% | 41.69B | |
+33.99% | 693B | |
+29.39% | 584B | |
-2.85% | 372B | |
+20.55% | 332B | |
+6.92% | 294B | |
+14.06% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.97% | 168B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical's Attributable Profit Falls 55% in Fiscal 2024